Results 111 to 120 of about 4,903,971 (217)

Bradycardia secondary to primary hyperparathyroidism

open access: yesJournal of International Medical Research, 2019
Clinical doctors rarely associate hyperparathyroidism with significant bradyarrhythmia. We report a rare case of a patient initially misdiagnosed with primary sick sinus syndrome, which was eventually shown to be secondary to primary hyperparathyroidism.
Fei Liu   +3 more
doaj   +1 more source

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism

open access: yesFrontiers in Endocrinology, 2018
Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy.
Giulia Di Dalmazi   +2 more
doaj   +1 more source

Parathyroidectomy Resolves Tooth Discoloration: A New Presenting Sign of Hyperparathyroidism?

open access: yesCase Reports in Dentistry, 2020
Introduction. We report the resolution of tooth discoloration following parathyroidectomy in an otherwise asymptomatic woman with primary hyperparathyroidism-associated hypercalcemia. Case Report.
Estella Musacchio   +4 more
doaj   +1 more source

Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002

open access: yesBrazilian Journal of Medical and Biological Research, 2005
In contrast to most developed countries, most patients with primary hyperparathyroidism in Brazil are still symptomatic at diagnosis. However, we have been observing a change in this pattern, especially in the last few years.
M.N. Ohe   +9 more
doaj   +1 more source

Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: A case report [PDF]

open access: yes, 2012
Although the pathological relationship between parathyroid and thyroid diseases is common, an association between parathyroid adenoma and thyroid cancer is rare.
Assadi, M.   +8 more
core   +1 more source

Usefulness of a rapid immunometric assay for intraoperative parathyroid hormone measurements [PDF]

open access: yes, 2003
Intraoperative parathyroid hormone (IO-PTH) measurements have been proposed to improve operative success rates in primary, secondary and tertiary hyperparathyroidism (PHP, SHP and THP).
Abrahão, Márcio   +7 more
core   +2 more sources

Selection of DNA Aptamers Against Parathyroid Hormone for Electrochemical Impedimetric Biosensor System Development

open access: yesBiotechnology and Applied Biochemistry, Volume 72, Issue 5, Page 1351-1362, October 2025.
ABSTRACT This work presents the pioneering development of an aptamer‐based electrochemical biosensor for real‐time monitoring of parathyroid hormone (PTH) levels, with a focus on intraoperative assessment during parathyroid surgery. It introduces, for the first time, the selection and characterization of aptamers targeting distinct segments of the PTH ...
Reza Didarian   +5 more
wiley   +1 more source

The Diagnostic Accuracy of High Resolution Ultrasound Imaging for Detection of Secondary Hyperparathyroidism in Patients with Chronic Renal Failure [PDF]

open access: yes
Ultrasound is one of the preferred modalities for evaluation of the parathyroid glands. This study was undertaken to determine the accuracy of high resolution ultrasound for secondary hyperparathyroidism in patients with chronic renal failure. From March
اناری, حسن   +3 more
core  

Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review

open access: yesFrontiers in Endocrinology, 2017
Introduction Primary hyperparathyroidism is increasingly an asymptomatic disease at diagnosis, but the recognized guidelines for management are based on evidence obtained from studies on patients with symptomatic disease, and surgery is not always ...
Julius Simoni Leere   +3 more
semanticscholar   +1 more source

Roxadustat for ESA‐Hyporesponsive Renal Anemia in a 13‐Year‐Old on Hemodialysis: Case Report and Mini‐Review

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
Changes in hemoglobin and iron metabolism parameters during Roxadustat treatment in a 13‐year‐old dialysis patient. ABSTRACT Anemia is the most common complication of end‐stage renal disease (ESRD). While erythropoiesis‐stimulating agents (ESA) have improved treatment outcomes, some patients exhibit intolerance or hyporesponsiveness.
Meng Zhang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy